Browsing: diabetes

Investing.com — Novo Nordisk (NYSE:) (CSE:) reported strong growth for the first nine months of 2024, with revenue increasing 23%…

By Sriparna Roy and Mariam Sunny (Reuters) -Advisors to the U.S. health regulator on Friday voted against the use of…

SHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, increasing competition with…